Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Efficacy and Safety of Nanofiltered C1 Inhibitor in HAE
NCT00119431Phase 2Completed
- Sponsor
- Prothya Biosolutions
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Human C1-esterase inhibitor in hereditary angioedema type I (HAE-I), sponsored by Prothya Biosolutions. Started Sep 2005; status: completed.
02
Drugs
Human C1-esterase inhibitor
03
Conditions
hereditary angioedema type I (HAE-I)
Beyond the preview
Go deeper on NCT00119431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119431.